Expand VALN Menu
VALN MENU

VALN Latest Press Releases

-- June 4, 2026 --

Valneva Announces Availability of Documentation for its Annual General Meeting Globe Newswire 1:00 AM

-- May 28, 2026 --

Valneva to Participate at U.S. and European Investor Conferences in June Globe Newswire 11:45 AM

-- May 13, 2026 --

Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates Globe Newswire 1:00 AM

-- May 5, 2026 --

Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Globe Newswire 11:45 AM

-- April 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN PRNewswire 10:40 PM
Valneva Announces the Successful Completion of an EUR 84 million Reserved Offering Globe Newswire 1:15 AM

-- April 28, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN Globe Newswire 6:26 PM

-- April 21, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE - VALN Globe Newswire 5:21 PM

-- April 16, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN PRNewswire 10:00 AM

-- April 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN Globe Newswire 5:11 PM

-- April 9, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN PRNewswire 10:01 AM

-- March 31, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN Globe Newswire 6:06 PM

-- March 26, 2026 --

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC Globe Newswire 12:45 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN PRNewswire 10:00 AM

-- March 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE - VALN Globe Newswire 5:49 PM

-- March 23, 2026 --

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial Business Wire 6:45 AM

-- March 18, 2026 --

Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program PRNewswire 8:00 AM
Valneva Reports Full Year 2025 Audited Consolidated Financial Results Globe Newswire 2:00 AM

-- March 9, 2026 --

Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026 Globe Newswire 12:45 PM

-- March 2, 2026 --

Valneva to Participate in Upcoming Investor Conferences Globe Newswire 11:45 AM

-- February 19, 2026 --

Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook Globe Newswire 1:00 AM

-- February 13, 2026 --

Valneva Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom Globe Newswire 11:45 AM

-- February 3, 2026 --

Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ Globe Newswire 1:00 AM

-- January 19, 2026 --

Valneva Provides Update on Chikungunya Vaccine IXCHIQ Globe Newswire 12:00 PM
Market Data Delayed 15 Minutes